Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04975763 · ClinicalTrials.gov registry record · NA

Dietary Oils to Sustain Energy Study

A NA study of Overweight and Obesity, sponsored by Ohio State University.

Active
Registry status
NA
Development phase
16
Enrollment target
1
Study location

NCT04975763: Active NA study of Overweight and Obesity, sponsored by Ohio State University.

NCT04975763 is a NA study of Overweight and Obesity that is active but no longer recruiting, run by Ohio State University. The registered enrollment target is 16 participants, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04975763, a NA study of Overweight and Obesity, is active but no longer recruiting, sponsored by Ohio State University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
16 participants
Enrollment target
1
Study location

Study Summary

The research study is an intervention and feasibility crossover design pilot study designed to assess if consuming 3 study foods made with either soybean oil or palm oil per day for 4 weeks can alter whole blood, plasma and erythrocyte fatty acids and body weight in overweight/obese adults. Additionally, the study will assess the adherence to consuming 3 study foods per day for 4 weeks and to assess if participant remain unaware of (or masked to) which study food group (soybean oil vs palm oil) they are consuming.

Primary Outcome

Determine changes in whole blood, plasma and erythrocyte linoleic acid in the soybean oil arm and determine the changes in whole blood, plasma and erythrocyte oleic acid and palmitic acid in the palm oil arm. Fatty acids for all sample types are reported as percent of total identified

Conditions Studied

Interventions

  • OTHER Soybean Oil Foods
  • OTHER Palm Oil Foods

Study Locations (1)

Ohio

  • The Ohio State University Human Nutrition Laboratory - Columbus

Trial Details

FieldValue
Enrollment Target 16 participants
Start Date 2021-07-19
Est. Completion 2025-12-30
Phase NA
Ohio State University

552 total trials

What the registry record for NCT04975763 still lists

NCT04975763 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 228-participant average among 115 other Overweight and Obesity trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Overweight and Obesity appearing as the primary indexed condition, and to 2 interventions - of which Soybean Oil Foods is the first listed.

NCT04975763 reports a single indexed study location in Ohio.

Frequently Asked Questions

What is clinical trial NCT04975763 about?

NCT04975763 is a clinical study titled "Dietary Oils to Sustain Energy Study". The research study is an intervention and feasibility crossover design pilot study designed to assess if consuming 3 study foods made with either soybean oil or palm oil per day for 4 weeks can alter whole blood, plasma and erythrocyte fatty acids and body weight in overweight/obese adults. Addition...

What is the current status of trial NCT04975763?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 16 participants. The study started on 2021-07-19. Estimated completion is 2025-12-30.

What conditions does trial NCT04975763 study?

This clinical trial studies the following conditions: Overweight and Obesity.

What interventions are being tested in trial NCT04975763?

The interventions under investigation include: Soybean Oil Foods (OTHER), Palm Oil Foods (OTHER).

Who is sponsoring clinical trial NCT04975763?

This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04975763 being conducted?

This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Overweight and Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT04975763's enrollment target sits among peer trials

16 110th of 115 higher than 6 of 115 other Overweight and Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Overweight and Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02422641 · 16 participants · Phase 2

    Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis

  • NCT02851758 · 16 participants · NA

    Transplantation of Autologously Derived Mitochondria Following Ischemia

  • NCT03291028 · 16 participants

    Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma

  • NCT03425526 · 16 participants · Phase 1

    Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04975763, the US trial registry maintained by the National Library of Medicine. NCT04975763 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.